Apelian David 4
4 · Eiger BioPharmaceuticals, Inc. · Filed Jul 6, 2023
Insider Transaction Report
Form 4
Apelian David
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-07-03+750,000→ 750,000 totalExercise: $0.73Exp: 2033-07-02→ Common Stock (750,000 underlying)
Footnotes (1)
- [F1]The option vests in equal monthly installments over 48 months measured from July 3, 2023, subject to the Reporting Person's continuous service as of each such date.